Results 101 to 110 of about 4,155 (158)

Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd study. [PDF]

open access: yesRMD Open, 2022
van der Heijde D   +10 more
europepmc   +1 more source

Upadacitinib in Active Non-radiographic Axial Spondyloarthritis: 1-Year Data From a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial. [PDF]

open access: yesACR Open Rheumatol
Van den Bosch F   +11 more
europepmc   +1 more source

Long-term clinical outcomes of certolizumab pegol treatment in non-radiographic axial spondyloarthritis stratified by baseline MRI and CRP status. [PDF]

open access: yesRMD Open
Rudwaleit M   +8 more
europepmc   +1 more source

Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis. [PDF]

open access: yesRheumatol Ther
Rubbert-Roth A   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy